7-(二苯甲基氧基)-1H-吲哚 | 135328-49-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 7-(二苯甲基氧基)-1H-吲哚
• 中文别名: 7-(二苯甲氧基)-1H-吲哚
• 英文名称: 7-benzhydryloxyindole
• 英文别名: 7-(benzhydryloxy)-1H-indole；7-(diphenylmethoxy)indole；7-benzhydrylindole；7-diphenylmethyl ether of indole；7-diphenylmethyloxy-1H-indole；7-benzhydryloxy-1H-indole
• CAS: 135328-49-3
• 化学式: C₂₁H₁₇NO
• 分子量: 299.372
• InChiKey: RUSLOKVULVVFGQ-UHFFFAOYSA-N

物化性质

• 沸点：
  491.4±30.0 °C(Predicted)
• 密度：
  1.195±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  25
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  7-(二苯甲基氧基)-1H-吲哚 在 4-二甲氨基吡啶 、 lithium hexamethyldisilazane 作用下， 以 四氢呋喃 、 正己烷 、 甲苯 为溶剂， 反应 28.0h， 生成 7-benzhydryloxy-3-[1-methyl-2,5-dioxo-4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-2,5-dihydro-1H-pyrrol-3-yl]indole-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  Synthesis and biological evaluation of 7-azaindolocarbazoles

  摘要：

  In the course of a program aimed at designing antitumor agents containing an indolocarbazole framework, an efficient synthetic scheme based on the use of 3,4-dibromo-N-methylmaleimide and 7-azaindole has been developed to elaborate a series of mono- and di-aza derivatives of arcyriaflavin. The procedure was further exploited to introduce a hydroxyl group at different positions on the indole moiety of the non-symmetrical compounds. The DNA binding capacity and cytotoxic potential of these 7-azaindolocarbazole derivatives was evaluated. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(02)00691-9
• 作为产物：
  描述：

  硝苯酚 在 potassium carbonate 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 6.75h， 生成 7-(二苯甲基氧基)-1H-吲哚
  参考文献：
  名称：

  Makaluvamine J及其类似物的统一合成及生物学评价

  摘要：

  Makaluvamine J 是一种源自海绵的吡咯亚氨基醌生物碱及其类似物，并对其类似物进行了合成和评估，以评估其开发为针对人胰腺癌 PANC-1 细胞的新型选择性生长抑制剂的潜力。 Ts-达米隆 B 是一种具有吡咯亚氨基醌核心结构的常见前体，通过 Bartoli 吲哚合成和 IBX 介导的氧化合成。 N-5 和 N-9 的后期多样化产生了 makaluvamine J 和几种类似物。构效关系 (SAR) 分析强调了 N-9 亲脂侧链对 PANC-1 细胞生长抑制活性的重要性。 N-5 处的适度烷基被发现可以提高针对其他癌细胞的选择性。在制备的类似物中，色胺类似物24表现出有效的选择性细胞毒性（IC50 = 0.029 µM，选择性指数= 13.1），超过了天然产物。

  DOI：

  10.3390/molecules29061389

文献信息

• Synthetic Approach to Telomerase Inhibitor Dictyodendrin B: Synthesis of the Pyrrolo[2,3-<i>c</i>]carbazole Core
  作者：Shotaro HIRAO、Yumiko SUGIYAMA、Masatomo IWAO、Fumito ISHIBASHI

  DOI：10.1271/bbb.90111

  日期：2009.8.23

  The core structure of the telomerase inhibitor, dictyodendrin B, was synthesized by using the palladium-catalyzed cross-coupling reaction of 3-aryl-1-(2-arylethyl)-4-hydroxy-2,5-bismethoxycarbonylpyrrole triflate with 7-alkoxyindole-3-boronate as the key step.

  利用3-芳基-1-（2-芳基乙基）-4-羟基-2,5-双甲氧基羰基吡咯三氟甲磺酸酯与7-烷氧基吲哚的钯催化交叉偶联反应，合成端粒酶抑制剂dictyodendrin B的核心结构。 -3-硼酸酯是关键步骤。
• Novel Approaches towards the LTD₄/E₄ Antagonist, LY290154
  作者：Alain Merschaert、Pascal Boquel、Jean-Pierre Van Hoeck、Hugo Gorissen、Alfio Borghese、Benjamin Bonnier、Anne Mockel、Freddy Napora

  DOI：10.1021/op060036x

  日期：2006.7.1

  Several novel approaches have been investigated for the synthesis of the LTD4/E4 antagonist LY290154. Significant improvements to the discovery route were first made by using an indoline nucleophile instead of an indolyl anion in the key substitution step. An alternative approach, introducing the 7-chloroquinoline moiety in the latest stages of the synthesis was then demonstrated. Interestingly, the

  已经研究了几种新颖的方法来合成LTD 4 / E 4拮抗剂LY290154。首先通过在关键取代步骤中使用二氢吲哚亲核试剂代替吲哚基阴离子对发现路线进行了重大改进。然后证明了另一种方法，在合成的最新阶段引入了7-氯喹啉部分。有趣的是，后一种方法的关键中间体也是按照Katritzky方法在一锅法中获得的。最后，证明了一种不对称合成方法，该方法相对于McKillop报告的对映选择性路线具有明显优势。
• Therapeutic diphenyl ether ligands
  申请人：Fliri J. Anton

  公开号：US20060058361A1

  公开（公告）日：2006-03-16

  This invention is directed to compounds of formula Ia, Ib or Ic and to pharmaceutical compositions thereof: or a prodrug thereof and a pharmaceutically acceptable carrier, wherein the R groups are defined in the specification; and, in which the dashed line represents an optional double bond. The invention is also directed to methods of treating, diagnosing, and preventing disorders of the central nervous system that are associated with 5HT receptors, including obesity, attention deficit disorder, migraine, depression, epilepsy, anxiety, Alzheimer's disease, withdrawal from drug abuse, pain, schizophrenia, stress-related disorders, panic disorder, sleep disorders, phobias, obsessive compulsive disorder, post-traumatic-stress syndrome, immune system depression, stress-induced gastrointestinal dysfunction, stress-induced cardiovascular dysfunction, and sexual dysfunction.

  该发明涉及式Ia、Ib或Ic的化合物，以及其药物组成物：或其前药和药用可接受载体，其中R基在规范中定义；以及虚线代表可选的双键。该发明还涉及治疗、诊断和预防与5HT受体相关的中枢神经系统疾病的方法，包括肥胖、注意缺陷障碍、偏头痛、抑郁症、癫痫、焦虑、阿尔茨海默病、戒毒、疼痛、精神分裂症、应激相关疾病、恐慌症、睡眠障碍、恐惧症、强迫症、创伤后应激综合征、免疫系统抑郁、应激引起的胃肠功能障碍、应激引起的心血管功能障碍和性功能障碍。
• Novel substituted [1,4] benzodioxino[2,3-e] isoindole derivatives, method for preparing and pharmaceutical compositions containing same
  申请人：Coudert Gerard

  公开号：US20060040930A1

  公开（公告）日：2006-02-23

  Compounds of formula (I): wherein: A is as defined in the description, Y represents a group selected from an oxygen atom and a methylene group, R 2 represents a hydrogen atom and in that case: R 3 represents a group selected from a hydrogen atom and the groups linear or branched (C 1 -C 6 )alkyl, aryl, aryl-(C 1 -C 6 )alkyl (in which the alkyl moiety is linear or branched) and SO 2 CF 3 , or R 2 and R 3 form a bond, R 1 represents a group selected from a hydrogen atom and the groups linear or branched (C 1 -C 6 )alkyl, aryl and aryl-(C 1 -C 6 )alkyl (in which the alkyl moiety is linear or branched) or a linear or branched (C 1 -C 6 )alkylene chain, Z 1 and Z 2 each represent a hydrogen atom or Z 1 and Z 2 , together with the carbon atoms carrying them, form a phenyl group. Medicaments.

  式(I)的化合物：其中：A如描述中定义，Y代表从氧原子和亚甲基组中选择的一个基团，R2代表氢原子，此时：R3代表从氢原子和线性或支链的(C1-C6)烷基，芳基，芳基-(C1-C6)烷基（其中烷基基团是线性或支链的）和SO2CF3中选择的一个基团，或者R2和R3形成键，R1代表从氢原子和线性或支链的(C1-C6)烷基，芳基和芳基-(C1-C6)烷基（其中烷基基团是线性或支链的）或线性或支链的(C1-C6)烷基链中选择的一个基团，Z1和Z2各自代表氢原子或Z1和Z2与携带它们的碳原子一起形成苯基。药物。
• Benzocarbapenems from indoles 1
  作者：Steven Coulton、Thomas L. Gilchrist、Keith Graham

  DOI：10.1039/a800278i

  日期：——

  The 8,8a-dihydroazeto[1,2-a]indol-2(1H)-ones (benzocarbapenems) 1a, 16, 17, 22, 27, 35 and 36 have been prepared by cyclodehydration of the corresponding β-amino acids, these amino acids being obtained by reduction of the analogous 2-substituted or 2,7-disubstituted indoles. The hydroxy group of compound 36 is designed to mimic the carboxylic acid function of the carbapenems on the basis of molecular modelling. The azetidinones 1a and 27, which are unsubstituted at the methylene group of the four-membered ring, are unstable and highly susceptible to ring opening by nucleophiles but the compounds 22, 35 and 36 with two methyl substituents at this position are much more stable. The carbonyl stretching frequency in the IR is close to 1770 cm–1 for all the azetidinones except the phenol 36 for which the absorption is at 1735 cm–1. An X-ray crystal structure of compound 36 is reported.

  8,8a-二氢氮杂环[1,2-a]吲哚-2(1H)-酮（苯并卡培南）1a、16、17、22、27、35和36是通过环脱水反应制备的，其前体为相应的β-氨基酸，这些氨基酸通过还原相应的2-取代或2,7-双取代吲哚获得。化合物36的羟基设计旨在模拟卡培南的羧酸功能，这是基于分子模型的结果。未取代四元环亚甲基的氮杂环酮1a和27不稳定，易受亲核试剂开环，但在该位置具有两个甲基取代基的化合物22、35和36则更为稳定。除了酚类化合物36的吸收频率在1735 cm–1外，所有氮杂环酮的羰基伸缩频率在红外光谱中都接近1770 cm–1。报告了化合物36的X射线晶体结构。